Americans preparing to enroll in 2026 Affordable Care Act (ACA) health insurance plans are facing steep premium hikes, with monthly costs expected to more than double on average. The sharp rise stems from the expiration of COVID-19 pandemic-era subsidies that have been central to the ongoing U.S. government shutdown. These subsidies, which boosted enrollment to a record 24 million since 2021, are set to expire at the end of the year, potentially increasing the number of uninsured Americans and influencing election outcomes.
According to health research firm KFF, ACA enrollees will see average premiums rise by 114%. While 22 million people currently receive subsidies, the impact will vary widely. For example, 24-year-old Californian Austin Jeha’s monthly premium is expected to jump from $215 to $436. Like many, he relies on his ACA plan for essential medical care and is urging Congress to extend the subsidies.
The budget impasse in Washington has left much of the government shuttered since October 1. Democrats are pushing to include ACA funding in any reopening deal, while Republicans insist on restoring government funding first. Residents of Republican-led states such as Florida, Texas, and Georgia are expected to be hit hardest, as limited Medicaid coverage forces many low-income workers to depend on ACA plans.
If subsidies expire, households earning just above 400% of the federal poverty line—around $84,600 for a couple—could see their premiums quadruple. Experts warn enrollment will decline even if subsidies are later reinstated, as consumers may abandon plans after seeing higher rates. The Congressional Budget Office estimates over 4 million Americans could lose coverage without renewed tax credits. Rising healthcare costs and insurer exits, such as CVS Health’s Aetna leaving the ACA market, have already driven a 26% increase in premiums. For many families, healthcare remains essential but increasingly unaffordable.


Democratic Attorneys General Sue Trump Administration Over CDC Childhood Vaccine Schedule Changes
Vanda Pharmaceuticals (VNDA) Stock Soars After FDA Approves BYSANTI for Bipolar I and Schizophrenia
Lula and Trump Talks Signal New Phase in Brazil-US Relations
Wall Street Futures Slip After Record Rally Fueled by Iran Peace Hopes and AMD Surge
Japan Tech Stocks Surge as AI Optimism Lifts SoftBank, Chipmakers
US Sanctions Target Iran’s Shadow Banking Network and Terror Financing
Oil Prices Rise Amid Strait of Hormuz Tensions and U.S.-Iran Ceasefire Uncertainty
Trump Administration Releases New UFO Files and Apollo Mission Records
Judge Rules DOGE Humanities Grant Cuts Unconstitutional
Dollar Weakens as Iran Peace Hopes Boost Risk Appetite and Yen Gains Strength
Russian LNG Shadow Fleet Expands Amid Arctic LNG 2 Sanctions
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales
The four types of dementia most people don’t know exist
Trump-Xi Meeting 2026: U.S.-China Trade Tensions Escalate Ahead of Beijing Summit
CDC Acting Director Urges Measles Vaccination as U.S. Cases Surge in 2026
Trump Inspects Lincoln Memorial Reflecting Pool Renovation in Washington 



